Ghent University Academic Bibliography


Project: Immuno histochemical validation of lungcancer specific antigens

project duration
01-MAY-03 – 30-APR-04
Immuno-therapy, in particular the use of monoclonal antibodies, is thought to be of great potential in the treatment of cancer. Using molecular techniques, Ganymed Pharmaceuticals identifies lung cancer specific antigens against whom antibodies can be directed. The distribution of the potential targets will be validated qualitatively and quantitatively in the Laboratory of Pathology of the University Hopsita Gent using immunohistochemistry